Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tetrodotoxin Open-label Efficacy and Safety Continuation Study (TEC-006OL)

This study has been completed.
Information provided by (Responsible Party):
Wex Pharmaceuticals Inc. Identifier:
First received: July 28, 2008
Last updated: October 22, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)